| Dr Jonathan Glenn Baker, MD | |
|
984 West Broadway, Suite 4, Jackson, WY 83001-0000 | |
| (307) 734-1800 | |
| (307) 734-5012 |
| Full Name | Dr Jonathan Glenn Baker |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 30 Years |
| Location | 984 West Broadway, Jackson, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447233754 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 8097A (Wyoming) | Primary |
| 207N00000X | Dermatology | A55560 (California) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Teton Dermatology Inc | 0042335333 | 6 |
News Archive
Scientists investigating the effects of cannabis on bone health have found that its impact varies dramatically with age.
Medicis today announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN (minocycline HCl, USP) Extended Release Tablets in 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
A catheter-mounted device that acts like a clothespin to clip together the flaps of a leaky heart valve is not only reducing the abnormal backflow of blood from the left ventricle to the left atrium, it is helping to shrink the enlarged, overworked heart and relieving symptoms of fluid overload - all without open-chest surgery.
More than six million people in the U.S. suffer from persistent wounds - open sores that never seem to heal or, once apparently healed, return with a vengeance. The bedridden elderly and infirm are prone to painful and dangerous pressure ulcers, and diabetics are susceptible to wounds caused by a lack of blood flow to the extremities.
The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.
› Verified 5 days ago
| Entity Name | Teton Dermatology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194044750 PECOS PAC ID: 0042335333 Enrollment ID: O20100909000829 |
News Archive
Scientists investigating the effects of cannabis on bone health have found that its impact varies dramatically with age.
Medicis today announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN (minocycline HCl, USP) Extended Release Tablets in 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
A catheter-mounted device that acts like a clothespin to clip together the flaps of a leaky heart valve is not only reducing the abnormal backflow of blood from the left ventricle to the left atrium, it is helping to shrink the enlarged, overworked heart and relieving symptoms of fluid overload - all without open-chest surgery.
More than six million people in the U.S. suffer from persistent wounds - open sores that never seem to heal or, once apparently healed, return with a vengeance. The bedridden elderly and infirm are prone to painful and dangerous pressure ulcers, and diabetics are susceptible to wounds caused by a lack of blood flow to the extremities.
The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Glenn Baker, MD Po Box 14510, Jackson, WY 83002-4510 Ph: (307) 734-1800 | Dr Jonathan Glenn Baker, MD 984 West Broadway, Suite 4, Jackson, WY 83001-0000 Ph: (307) 734-1800 |
News Archive
Scientists investigating the effects of cannabis on bone health have found that its impact varies dramatically with age.
Medicis today announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN (minocycline HCl, USP) Extended Release Tablets in 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
A catheter-mounted device that acts like a clothespin to clip together the flaps of a leaky heart valve is not only reducing the abnormal backflow of blood from the left ventricle to the left atrium, it is helping to shrink the enlarged, overworked heart and relieving symptoms of fluid overload - all without open-chest surgery.
More than six million people in the U.S. suffer from persistent wounds - open sores that never seem to heal or, once apparently healed, return with a vengeance. The bedridden elderly and infirm are prone to painful and dangerous pressure ulcers, and diabetics are susceptible to wounds caused by a lack of blood flow to the extremities.
The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.
› Verified 5 days ago
Dr. Brittany Wilson Baker, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 984 W Broadway, Suite 4, Jackson, WY 83001 Phone: 307-734-1800 Fax: 307-734-5012 | |
Afton Chavez Cobb, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 62 Redmond St, Jackson, WY 83001 Phone: 505-514-8705 |